Literature DB >> 10704364

Progesterone regulates the accumulation and the activation of Eg2 kinase in Xenopus oocytes.

M Frank-Vaillant1, O Haccard, C Thibier, R Ozon, Y Arlot-Bonnemains, C Prigent, C Jessus.   

Abstract

Xenopus prophase oocytes reenter meiotic division in response to progesterone. The signaling pathway leading to Cdc2 activation depends on neosynthesized proteins and a decrease in PKA activity. We demonstrate that Eg2 protein, a Xenopus member of the Aurora/Ipl1 family of protein kinases, accumulates in response to progesterone and is degraded after parthenogenetic activation. The polyadenylation and cap ribose methylation of Eg2 mRNA are not needed for the protein accumulation. Eg2 protein accumulation is induced by progesterone through a decrease in PKA activity, upstream of Cdc2 activation. Eg2 kinase activity is undetectable in prophase and is raised in parallel with Cdc2 activation. In contrast to Eg2 protein accumulation, Eg2 kinase activation is under Cdc2 control. Furthermore, by using an anti-sense strategy, we show that Eg2 accumulation is not required in the transduction pathway leading to Cdc2 activation. Altogether, our results strongly suggest that Eg2 is not necessary for Cdc2 activation, though it could participate in the organization of the meiotic spindles, in agreement with the well-conserved roles of the members of the Aurora family, from yeast to man.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704364     DOI: 10.1242/jcs.113.7.1127

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  24 in total

1.  APC/Fizzy-Related targets Aurora-A kinase for proteolysis.

Authors:  Anna Castro; Yannick Arlot-Bonnemains; Suzanne Vigneron; Jean-Claude Labbé; Claude Prigent; Thierry Lorca
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

2.  Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation.

Authors:  Karthik Arumugam; Melanie C Macnicol; Angus M Macnicol
Journal:  Mol Reprod Dev       Date:  2012-07-09       Impact factor: 2.609

Review 3.  Vertebrate Reproduction.

Authors:  Sally Kornbluth; Rafael Fissore
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-10-01       Impact factor: 10.005

4.  Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.

Authors:  Karthik Arumugam; Yiying Wang; Linda L Hardy; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

5.  Translational control of gurken mRNA in Drosophila development.

Authors:  Christopher J Derrick; Timothy T Weil
Journal:  Cell Cycle       Date:  2016-11-14       Impact factor: 4.534

6.  Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.

Authors:  Laurie E Littlepage; Joan V Ruderman
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

7.  Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin.

Authors:  Bedrick B Gadea; Joan V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

8.  Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3.

Authors:  Madathia Sarkissian; Raul Mendez; Joel D Richter
Journal:  Genes Dev       Date:  2004-01-01       Impact factor: 11.361

9.  Evolutionary relationships of Aurora kinases: implications for model organism studies and the development of anti-cancer drugs.

Authors:  James R Brown; Kristin K Koretke; Marian L Birkeland; Philippe Sanseau; Denis R Patrick
Journal:  BMC Evol Biol       Date:  2004-10-12       Impact factor: 3.260

10.  Ca2+ homeostasis regulates Xenopus oocyte maturation.

Authors:  Lu Sun; Rawad Hodeify; Shirley Haun; Amanda Charlesworth; Angus M MacNicol; Subramaniam Ponnappan; Usha Ponnappan; Claude Prigent; Khaled Machaca
Journal:  Biol Reprod       Date:  2007-12-19       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.